Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Inventory Average of $30.0 million for Q1 2026, up 92.76% year-over-year from $15.6 million in Q1 2025, and up 33.23% quarter-over-quarter from $22.5 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- In Q1 2026, Inventory Average rose 92.76% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 92.76% YoY), while the FY2025 annual figure was $18.6 million, up 34.35% from the prior year.
- Inventory Average for Q1 2026 stood at $30.0 million, up from $22.5 million in the prior quarter.
- The five-year high for Inventory Average was $30.0 million in Q1 2026, with the low at $5.9 million in Q4 2022.
- The 5-year median for Inventory Average is $13.8 million (2024), against an average of $14.9 million.
- The sharpest annual moves came in 2023 and 2024: Inventory Average surged 128.8% in 2023, then advanced 5.52% in 2024.
- Arcutis Biotherapeutics' Inventory Average stood at $5.9 million in 2022, then soared by 128.8% to $13.5 million in 2023, then increased by 5.52% to $14.3 million in 2024, then surged by 57.85% to $22.5 million in 2025, then jumped by 33.23% to $30.0 million in 2026.
- Business Quant data shows ARQT's Inventory Average at $30.0 million in Q1 2026, $22.5 million in Q4 2025, and $19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 38.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.14 Mn |
| Mar 31, 2026 | 30.01 Mn |
| Dec 31, 2025 | 22.53 Mn |
| Sep 30, 2025 | 19.37 Mn |
| Jun 30, 2025 | 16.47 Mn |
| Mar 31, 2025 | 15.57 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 13.95 Mn |
| Jun 30, 2024 | 13.56 Mn |
| Mar 31, 2024 | 13.19 Mn |
| Dec 31, 2023 | 13.52 Mn |
| Sep 30, 2023 | 12.19 Mn |
| Jun 30, 2023 | 9.51 Mn |
| Mar 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 5.91 Mn |